Related Experiment Video
Updated: Jan 19, 2026

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo
Published on: June 29, 2022
Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses
Lokesh A Kalekar1, Jarish N Cohen1, Nicolas Prevel1
1Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.
Abstract:
At the center of fibrosing diseases is the aberrant activation of tissue fibroblasts. The cellular and molecular mechanisms of how the immune system augments fibroblast activation have been described; however, little is known about how the immune system controls fibroblast function in tissues. Here, we identify regulatory T cells (Tregs) as important regulators of fibroblast activation in skin. Bulk cell and single-cell analysis of Tregs in murine skin and lungs revealed that Tregs in skin are transcriptionally distinct and skewed toward T helper 2 (TH2) differentiation. When compared with Tregs in lung, skin Tregs preferentially expressed high levels of GATA3, the master TH2 transcription factor. Genes regulated by GATA3 were highly enriched in skin "TH2 Treg" subsets. In functional experiments, Treg depletion resulted in a preferential increase in TH2 cytokine production in skin. Both acute depletion and chronic reduction of Tregs resulted in spontaneous skin fibroblast activation, profibrotic gene expression, and dermal fibrosis, all of which were exacerbated in a bleomycin-induced murine model of skin sclerosis. Lineage-specific deletion of Gata3 in Tregs resulted in an exacerbation of TH2 cytokine secretion that was preferential to skin, resulting in enhanced fibroblast activation and dermal fibrosis. Together, we demonstrate that Tregs play a critical role in regulating fibroblast activation in skin and do so by expressing a unique tissue-restricted transcriptional program that is mediated, at least in part, by GATA3.
More Related Videos
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Related Concept Videos
08:23Xenograft Skin Model to Manipulate Human Immune Responses In Vivo
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Humoral Immune Responses
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
04:00A Murine Skin Wound Infection Model to Study the Immune Response against a Bacterial Pathogen